🇰🇷 South Korea Country × Condition
coronary artery disease Clinical Trials in South Korea
Active clinical trials for coronary artery disease with research sites in South Korea. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 12 // Recruiting: 12 Phases: Phase 4 // Updated: Daily
Total Trials
12
Recruiting Now
12
Country
🇰🇷 South Korea
Active Trials in South Korea (12)
NCT06767345 Phase 4
Recruiting
Comparison of Moderate-Intensity Statin Plus Ezetimibe vs. High-Intensity Statin for Coronary Plaque Stabilization
Enrollment
408 pts
Country
🇰🇷 South Korea
Korea University Anam Hospital
View Trial → NCT07068490
Recruiting
Impact of Potassium Competitive Acid Blockers After Percutaneous Coronary Intervention for Efficacy and Safety Outcome: Target Trial Emulation Study.
Enrollment
100,000 pts
Country
🇰🇷 South Korea
Samsung Medical Center
View Trial → NCT02038127
Recruiting
Gangwon PCI Prospective Registry
Enrollment
5,000 pts
Country
🇰🇷 South Korea
Yonsei University
View Trial → NCT06182683
Recruiting
Concurrent OCT and FFR-guided PCI in CAD
Enrollment
700 pts
Country
🇰🇷 South Korea
Korea University Guro Hospital
View Trial → NCT05807841
Recruiting
Clinical Impact of Intravascular Ultrasound-Based Artificial Intelligence Technologies (INNOVATE-PCI)
Enrollment
3,000 pts
Country
🇰🇷 South Korea
Asan Medical Center
View Trial → NCT06186037 Phase 4
Recruiting
Clinical Comparison of Low-dose Rosuvastatin Plus Ezetimibe Combination Therapy and High-dose Rosuvastatin Monotherapy in Patients With Minimal to Intermediate Coronary Artery Disease Without Percutaneous Coronary Intervention
Enrollment
6,356 pts
Country
🇰🇷 South Korea
Saint Vincent's Hospital, Korea
View Trial → NCT05044273
Recruiting
Evaluation of Effectiveness and Safety of Synergy XD and Synergy Megatron™ Stent
Enrollment
2,000 pts
Country
🇰🇷 South Korea
Jung-min Ahn
View Trial → NCT06577896
Recruiting
The Study to Evaluate the Safety and Efficacy of the Onyx Family
Enrollment
500 pts
Country
🇰🇷 South Korea
Pusan National University Yangsan H...
View Trial → NCT06177743
Recruiting
IRIS-Coroflex NEO Cohort
Enrollment
1,000 pts
Country
🇰🇷 South Korea
Seung-Jung Park
View Trial → NCT01186133
Recruiting
Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice
Enrollment
50,000 pts
Country
🇰🇷 South Korea
Seung-Jung Park
View Trial → NCT05427786 Phase 4
Recruiting
A Study to Evaluate the Impact of Pre-procedural Intracoronary Nicorandil Injection to PREVENT ReductioN of DecREased TIMI FLOW in Patients Who Undergoing Percutaneous Coronary Intervention for the Coronary Artery Disease
Enrollment
460 pts
Country
🇰🇷 South Korea
Korea University Anam Hospital
View Trial → NCT05438121
Recruiting
STabilization of Atheroma by Lipid-reducing Effect of Drug-Coated Balloon (STABLE-DCB)
Enrollment
65 pts
Country
🇰🇷 South Korea
Korea University Ansan Hospital
View Trial → Frequently Asked Questions
How many coronary artery disease clinical trials are active in South Korea?
There are currently 12 active clinical trials for coronary artery disease with sites in South Korea, of which 12 are actively recruiting patients.
How can I join a coronary artery disease clinical trial in South Korea?
To join a coronary artery disease clinical trial in South Korea, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in South Korea directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are coronary artery disease trials in South Korea?
Active coronary artery disease trials in South Korea span Phase 4. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.